Review Topical Sections

Smart systems related to polypeptide sequences

  • Increasing interest for the application of polypeptide-based smart systems in the biomedical field has developed due to the advantages given by the peptidic sequence. This is due to characteristics of these systems, which include: biocompatibility, potential control of degradation, capability to provide a rich repertoire of biologically specific interactions, feasibility to self-assemble, possibility to combine different functionalities, and capability to give an environmentally responsive behavior. Recently, applications concerning the development of these systems are receiving greater attention since a targeted and programmable release of drugs (e.g. anti-cancer agents) can be achieved. Block copolymers are discussed due to their capability to render differently assembled architectures. Hybrid systems based on silica nanoparticles are also discussed. In both cases, the selected systems must be able to undergo fast changes in properties like solubility, shape, and dissociation or swelling capabilities. This review is structured in different chapters which explain the most recent advances on smart systems depending on the stimuli to which they are sensitive. Amphiphilic block copolymers based on polyanionic or polycationic peptides are, for example, typically employed for obtaining pH-responsive systems. Elastin-like polypeptides are usually used as thermoresponsive polymers, but performance can be increased by using techniques which utilize layer-by-layer electrostatic self-assembly. This approach offers a great potential to create multilayered systems, including nanocapsules, with different functionality. Recent strategies developed to get redox-, magnetic-, ultrasound-, enzyme-, light- and electric-responsive systems are extensively discussed. Finally, some indications concerning the possibilities of multi-responsive systems are discussed.

    Citation: Lourdes Franco, Luís J. del Valle, Jordi Puiggalí. Smart systems related to polypeptide sequences[J]. AIMS Materials Science, 2016, 3(1): 289-323. doi: 10.3934/matersci.2016.1.289

    Related Papers:

    [1] Vishanth Uppu, Kunal Mishra, Libin K. Babu, Ranji Vaidyanathan . Understanding the influence of graphene and nonclay on the microcracks developed at cryogenic temperature. AIMS Materials Science, 2019, 6(4): 559-566. doi: 10.3934/matersci.2019.4.559
    [2] Rong Ming Lin . Elastic Buckling Behaviour of General Multi-Layered Graphene Sheets. AIMS Materials Science, 2015, 2(2): 61-78. doi: 10.3934/matersci.2015.2.61
    [3] Tetyana Torchynska, Brenda Perez Millan, Georgiy Polupan, Mykola Kakazey . Surface modification in mixture of ZnO + 3%C nanocrystals stimulated by mechanical processing. AIMS Materials Science, 2016, 3(1): 204-213. doi: 10.3934/matersci.2016.1.204
    [4] Dinesh Rangappa, Erabhoina Hari Mohan, Varma Siddhartha, Raghavan Gopalan, Tata Narasinga Rao . Preparation of LiMn2O4 Graphene Hybrid Nanostructure by Combustion Synthesis and Their Electrochemical Properties. AIMS Materials Science, 2014, 1(4): 174-183. doi: 10.3934/matersci.2014.4.174
    [5] Nur Ezyanie Safie, Mohd Asyadi Azam . Understanding the structural properties of feasible chemically reduced graphene. AIMS Materials Science, 2022, 9(4): 617-627. doi: 10.3934/matersci.2022037
    [6] M. P. Lavin-Lopez, L. Sanchez-Silva, J. L. Valverde, A. Romero . CVD-graphene growth on different polycrystalline transition metals. AIMS Materials Science, 2017, 4(1): 194-208. doi: 10.3934/matersci.2017.1.194
    [7] Navin Kafle, Alper Buldum . The interaction between fullerene-porphyrin dyad and graphene. AIMS Materials Science, 2017, 4(2): 505-514. doi: 10.3934/matersci.2017.2.505
    [8] Ruijin Hong, Jialin Ji, Chunxian Tao, Daohua Zhang, Dawei Zhang . Fabrication of Au/graphene oxide/Ag sandwich structure thin film and its tunable energetics and tailorable optical properties. AIMS Materials Science, 2017, 4(1): 223-230. doi: 10.3934/matersci.2017.1.223
    [9] Rasheed Atif, Fawad Inam . Fractography analysis of 0.5 wt% multi-layer graphene/nanoclayreinforced epoxy nanocomposites. AIMS Materials Science, 2016, 3(3): 1266-1280. doi: 10.3934/matersci.2016.3.1266
    [10] Paul Plachinda, David Evans, Raj Solanki . Electrical properties of covalently functionalized graphene. AIMS Materials Science, 2017, 4(2): 340-362. doi: 10.3934/matersci.2017.2.340
  • Increasing interest for the application of polypeptide-based smart systems in the biomedical field has developed due to the advantages given by the peptidic sequence. This is due to characteristics of these systems, which include: biocompatibility, potential control of degradation, capability to provide a rich repertoire of biologically specific interactions, feasibility to self-assemble, possibility to combine different functionalities, and capability to give an environmentally responsive behavior. Recently, applications concerning the development of these systems are receiving greater attention since a targeted and programmable release of drugs (e.g. anti-cancer agents) can be achieved. Block copolymers are discussed due to their capability to render differently assembled architectures. Hybrid systems based on silica nanoparticles are also discussed. In both cases, the selected systems must be able to undergo fast changes in properties like solubility, shape, and dissociation or swelling capabilities. This review is structured in different chapters which explain the most recent advances on smart systems depending on the stimuli to which they are sensitive. Amphiphilic block copolymers based on polyanionic or polycationic peptides are, for example, typically employed for obtaining pH-responsive systems. Elastin-like polypeptides are usually used as thermoresponsive polymers, but performance can be increased by using techniques which utilize layer-by-layer electrostatic self-assembly. This approach offers a great potential to create multilayered systems, including nanocapsules, with different functionality. Recent strategies developed to get redox-, magnetic-, ultrasound-, enzyme-, light- and electric-responsive systems are extensively discussed. Finally, some indications concerning the possibilities of multi-responsive systems are discussed.


    In recent years, sepsis, a severe and complex infectious disease, has imposed a tremendous burden on global healthcare systems. Accurately predicting the occurrence and progression of sepsis is crucial for timely intervention and treatment, aiming to reduce patient suffering and improve survival rates. It is one of the leading causes of death for patients in ICUs, characterized by tissue damage, organ dysfunction, and ultimately death, triggered by infection [1]. Over the past decade, approximately $ 30 $ million people worldwide (including $ 4.2 $ million newborns and children) have suffered from sepsis, and approximately $ 6 $ million patients have died. The average annual incidence of sepsis is $ 437 $ cases per $ 100, 000 $ people [2,3]. Severe sepsis exacerbates multiple organ failure [4], with a mortality rate of $ 9.7\% $ [5]. Especially in patients with infectious shock symptoms, the mortality rate can increase to over $ 40\% $ [6]. Studies have shown that for every hour of delay in physicians making diagnostic conclusions, the mortality rate of patients increases by $ 7.6\% $ [7]. However, there is currently a lack of an effective method to address this medical problem. Developing an intelligent diagnostic early warning model to identify the risk of contracting sepsis and recommend timely therapeutic measures would significantly reduce the risk of patient death.

    Predicting the incidence of sepsis is a rigorous scientific challenge in medical diagnosis. It requires empirical analysis and experience summary based on real patient EMRs to provide data sources for subsequent clinical assistant diagnosis and treatment evaluation. Despite the widespread application of artificial intelligence techniques in the field of smart healthcare [8,9,10], in real-world medical scenarios, EMR data is complex in structure, and diagnostic information carries a high degree of uncertainty. Therefore, current existing methods still face challenges in accurately predicting the onset of sepsis and cannot be widely applied for clinical assistant diagnosis.

    The main challenge in accurately predicting the incidence of sepsis in ICU patients based on EMRs includes the following two aspects. First, the presence of numerous time-series features in EMRs complicates modeling, analysis, and clinical application. Time-series features in EMRs are crucial for early warning sepsis surveillance. However, the uncertainty of physiological data and laboratory test results at specific time intervals complicates modeling and analysis. Existing methods often utilize data from a single time point, disregarding the time-series nature of the data. Although recurrent neural network (RNN) technologies are commonly used for modeling time-series data [11], the RNN structure can suffer from issues like gradient disappearance and gradient explosion, particularly when dealing with longer time intervals, resulting in poor prediction outcomes. Therefore, it is necessary to construct a sepsis prediction model that incorporates time-series features for clinical assistant diagnosis.

    Second, there were numerous missing values in the EMRs. The problem of missing data is primarily due to doctors' failure to record specific patient information or data corruption caused by other reasons. However, the issue of missing values in the data may also be caused by the variability of practice guidelines in daily medical management. For example, for patients with stable conditions, their respiratory rate, heart rate, body temperature, and other physiological signs are usually recorded every $ 3 $ to $ 4 $ hours. However, for patients in the ICU, these signs must be recorded every hour[12]. These variations in data collection intervals contribute to missing values in the EMRs, which further complicates the prediction of sepsis incidence.

    Traditionally, researchers have adopted the method of deleting or averaging to solve the problem of missing data. However, these methods do not consider the uncertainty of medical data, which may lead to severe prediction bias or invalid diagnostic conclusions.

    In this study, we propose a temporal convolution attention model for sepsis clinical assistant diagnosis prediction (TCASP). The contributions of this study are summarized as follows:

    1) We propose the TCASP model, which inputs multivariate time-series features into a temporal convolutional network (TCN) and combines the attention mechanism. Based on the TCASP model, we solved the modeling and clinical application problems of time-series data in a sepsis prediction model so that the physiological sign data and laboratory test results of patients' time-series nature can be fully mined and applied. The TCASP model effectively improved the prediction accuracy of sepsis and reduced the mortality of patients with sepsis.

    2) We model the covariance of the EMRs and use the multitask Gaussian process (MGP) to generate a continuous function fitting for irregular sample data to fill in the missing values in the EMRs, effectively solved the uncertainty of the data in the prediction of sepsis.

    3) We conducted numerous experiments on the international open source real EMRs dataset MIMIC-Ⅲ. Experiments have shown that the TCASP model is superior to traditional machine learning and deep learning models in terms of prediction accuracy, effectiveness, and stability.

    The remainder of this paper is organized as follows. In Section 2, we present related work. Section 3 focuses on the methodology and discusses the details of the TCASP model. Section 4 presents the results of our empirical evaluation of TCASP using the MIMIC-Ⅲ dataset. Finally, we discuss concluding remarks and research directions in Section 5.

    In recent years, various methods have been proposed for detecting sepsis in ICU [13,14,15,16,17]. These methods have been selectively compared to the simple clinical scoring criterion known as systemic inflammatory response syndrome (SIRS) [18]. However, the SIRS clinical scoring criterion does not provide the capability for continuous assessment of sepsis risk. In addition to SIRS, sequential organ failure assessment (SOFA) score [19] and modified early warning score (MEWS) [20] are commonly used in clinical practice. These methods involve manual tabulation and analysis of patients' vital signs and laboratory results to generate risk scores and have been validated for sepsis detection in multiple studies [21,22,23]. However, the effectiveness of these scoring systems is limited, partly because they do not consider the temporal trends in patient data and correlations between measurements. Henry et al.[24] introduced a targeted real-time warning score system called TEWScore for predicting septic shock. Horng et al.[25] developed automated triggers using machine learning techniques in the triage process of the emergency department to support clinical decision-making for sepsis. Nemati et al.[26] proposed an interpretable machine learning model aimed at improving the predictive accuracy of sepsis and providing explanations for the prediction results. Although these machine learning methods have demonstrated superior predictive performance compared to existing simple clinical approaches, they have not adequately addressed the issue of long time-series features in clinical medical data.

    Time series prediction is a method that utilizes historical data of past observations to predict future time points or intervals, and it finds wide applications in various fields [27,28,29]. Within the context of time series and sequential data modeling, recurrent neural networks (RNNs) have been recognized as commonly used approaches due to their powerful predictive capabilities and ability to capture variable-length observations and long-term temporal dependencies. Several RNN-based architectures have been developed for sepsis prediction in longitudinal medical records, where comprehensive medical records of the same patient at different time points are considered. For instance, Kam et al. [11] leveraged the commonly used LSTM architecture in deep learning to learn sequential patterns from medical data, thereby enhancing feature extraction performance and applying it to sepsis onset prediction. Lin et al.[30] proposed a convolutional-LSTM model that combines static and dynamic information for early diagnosis and prediction of sepsis. Baral et al.[31] introduced an enhanced bidirectional LSTM network for early prediction of cardiac arrest in sepsis patients. Rafiei et al.[32] presented a novel technique called smart sepsis predictor (SSP) to forecast sepsis onset in ICU patients. Saqib et al.[33] combined traditional machine learning techniques with LSTM to enable early prediction of sepsis in electronic medical records. However, the long-term temporal dependencies inherent in the RNN structure can lead to the vanishing or exploding gradient problems, which subsequently degrade the predictive performance of RNN models.

    Bahdanau et al. [34] first applied the attention mechanism to natural language processing to achieve simultaneous alignment and translation, solving a potential problem of the previous use of the encoder–decoder architecture in machine translation, that is, the information is compressed in a fixed-length vector that cannot correspond to long sentences. With the continuous development of attention mechanisms, various models incorporating attention have been proposed and applied in the healthcare field. By focusing limited attention on crucial information, attention mechanisms can save resources and rapidly acquire the most effective information. Consequently, it has been demonstrated that attention mechanisms significantly enhance model performance. For example, Choi et al. [35] proposed a reverse temporal attention model (RETAIN), which generates attention weights through a reverse recurrent network for detecting important clinical variables; Usama et al. [36] proposed a self-attention-based recurrent convolutional neural network (RCNN) model for assisting disease diagnosis by automatically learning advanced semantic features from clinical text using bidirectional recurrent connections in convolutions. However, the mentioned model utilized an RNN architecture that is slow to train and suffers from the vanishing gradient problem. Lan et al. [37] introduced an end-to-end computational model based on graph attention network for lncRNA-disease association prediction (GANLDA). Lin et al. [38] proposed a hierarchical attention temporal convolutional network (HA-TCN) architecture for diagnosing myotonic dystrophy from grip force time-series data, but such methods for disease prediction only focus on time points and do not consider different features. The attention-based mechanism of the TCASP proposed in this study can address these problems.

    Let the set of ICU patients $ H = \{h_1, h_2, \cdots, h_n \} $, $ h_t = \{Z_t|temp_k, heartrate_k, spo2_k, \cdots\} $, and the feature vector $ Z_t $ represent the ICU monitoring information, such as "body temperature", "heart rate" and "pulse oximetry", of ICU patient $ h $ at time point $ t $. The patient's stay in ICU is a continuous time interval $ T $, $ T = \{t_1, t_2, \cdots, t_j \} $. Subsequently, we let $ Z_c = \bigcup\limits^j\limits_{t = 1}Z_t $ denote the multivariate time series features vector $ Z $ of patient $ c $ at all time points during hospitalization. The problem of sepsis prediction can be formalized as follows: given the multivariate time-series features vector $ Z $ of $ T $ in ICU patient $ h $ during hospitalization, the decision goal is to calculate the probability $ p_h = $TCASP$ (h, T, Z) $ of sepsis in patient $ h $ through the TCASP model.

    We propose the TCASP for sepsis diagnosis prediction, as shown in Figure 1. The model comprises four parts: a multivariate time-series feature vector $ Z $ input module, a temporal convolutional network module, an attention mechanism module, and a prediction module. The overall prediction process is as follows: first, the multivariate time series features of patients were obtained and input into the time convolutional network for feature learning; then, the extracted features are assigned different weights according to the feature channel attention and the time channel attention; finally, the probability of sepsis infection in this patient is derived using the softmax activation function.

    Figure 1.  Overall framework of TCASP.

    Our proposed model uses an MGP [39] to preprocess the data. This method can handle irregular sampling frequencies, as shown in Figure 2. The MGP draws from the posterior distribution of a given observation at uniformly spaced grid times (hourly). More precisely, given irregularly sampled observations of $ i $ (value and time) $ \{y_i, t_i\} $, for uniformly spaced query times $ x_i $, the MGP plots a potential time series $ z_i $ based on the posterior distribution $ P(z_i|y_i, t_i, x_i, \theta) $, as shown in Eq (3.1). The processed $ z_i $ is used as the input to the temporal convolutional network.

    $ ziN(μ(zi),Σ(zi);θ)
    $
    (3.1)
    Figure 2.  Multitask Gaussian process (MGP).

    Mean $ \mu(z_i) $, and covariance $ \Sigma(z_i) $ are, respectively:

    $ μ(zi)=(KDKXiTi)(KDKTi+DI)1yi
    $
    (3.2)
    $ Σ(zi)=(KDKXi)(KDKXiTi)(KDKTi+DI)1(KDKTiXi)
    $
    (3.3)

    where $ K^{X_iT_i} $ is the correlation matrix between the uniformly spaced data query $ x_i $ and the data fitting $ t_i $, whereas denotes the correlation between $ x_i $ and itself. $ K^D $ is the task similarity kernel matrix whose $ K^D_{d, d'} $ at position $ (d, d') $ denotes the similarity tasks (i.e., time-series channels) $ d $ and $ d' $. Here, $ \otimes $ denotes the tensor product, $ K^{T_i} $ denotes the specific $ T_i $ correlation matrix between all observed times encountered by patient $ i $, and $ D $ is the diagonal matrix satisfying the pertask noise variance of $ D_{dd} = \sigma^2_{d} $, with $ i $ is the unit matrix. The posterior mean $ \mu(z_i) $ also depends on the observation $ y_i $. We collect the parameters of the MGP in $ \theta = \{ K^D, \sigma^2_{d}|^D_{d = 1}, l \} $, where $ l $ denotes the length scale of the kernel function.

    In the TCASP model, The multivariate time series feature vector $ Z_t $ of ICU patients was processed by MGP to obtain $ Z_i $, which was input into the time convolutional network. The temporal convolutional network adds a dilated causal convolution based on a one-dimensional convolution. The causal convolution ensures that the output of the model at time $ t $ depends only on the information at $ t $ and the moments before $ t $ and does not depend on the information after time $ t $ to prevent future information leakage. The dilated causal convolution is illustrated in Figure 3.

    Figure 3.  Dilated causal convolution.

    For one-dimensional input sequence $ x\in\mathbb{R}^n $ and a filter $ f:\{0, 1, \cdots, k-1 \} \rightarrow \mathbb{R} $, the dilated convolution operation $ F $ on element $ s $ of the sequence is defined as

    $ F(s)=(xdf)(s)=ki=0f(i)xsdi
    $
    (3.4)

    where $ d $ is the expansion factor, $ k $ is the filter size, $ x_{s-d\cdot i} $ represents the input sequence data, and input the sequence data $ \{x_0, x_1, \cdots, x_t \} $ that need to be learned into the cause-and-effect extended convolution learning feature $ F_{tr} $, and it can be seen from Figure 3 that when the number of neural network layers is large enough, the temporal convolutional network can learn all the input feature data and produce highly accurate prediction results.

    Meanwhile, in order to avoid network degradation in the deep model, the temporal convolutional network adds residual connections between the convolutional layers. The output result of conversion $ F $ and the input $ x $ of this module are added together as the output result $ F_{tr} = Activation(x+F(x)) $ of the residual block, and the feature $ F_{tr} $ learned by the residual block is corrected.

    Medical datasets contain monitoring data of multiple patient physiological features that reflect changes in patient physiological features, but not all physiological features extracted by temporal convolutional networks are associated with sepsis. Therefore, this study proposes using feature channel attention to address this issue.

    If the transformation in the temporal convolutional network is $ U = F_{tr}(X) $, $ F_{tr} $ is denoted as a feature, if $ X $ is an input, then $ X\in\mathbb{R}^{T\times N} $; if $ X $ is the output result of the intermediate layer, then $ X\in\mathbb{R}^{T\times N\times C'} $. To facilitate the model description, this study used the output result $ X\in\mathbb{R}^{T\times N\times C'} $ of the middle layer, and the operation of $ X $ as an input was similar to its operation as an output of the middle layer. $ U\in\mathbb{R}^{T\times N\times C'} $, where $ T $ is the sequence length, $ N $ is the number of vital sign measurement terms, $ C' $ and $ C $ and are the number of channels.

    First, $ 1\times1 $ convolution is used in the original convolution result $ U $ to obtain the life feature channel attention $ m $, as shown in Eq (3.5).

    $ m=V1×1U
    $
    (3.5)

    where $ m\in\mathbb{R}^{T\times N} $ is the learned feature attention, $ V_{1\times1} $ is a convolution kernel, $ U\in\mathbb{R}^{T\times N\times C'} $ is a transform in TCN, and $ \ast $ is a convolution operation.

    The feature channel attention and convolution results are then multiplied simultaneously as the result $ \bar{x}_c $ output, as shown in Eq (3.6):

    $ ˉxc=muc
    $
    (3.6)

    The size of the feature channel attention matrix is similar to that of the original convolution result, and the feature channel attention matrix is multiplied by the results under different channels as the result output.

    Where $ \bar{X} = \{\bar{x}_1, \bar{x}_2, \cdots, \bar{x}_c \} $, $ u_c $ is the convolution result $ U $ under the cth channel.

    Considering the interrelationship between channels, Hu et al. [40] introduced a novel structural unit- squeeze-and-excitation (SE) module in a CNN. The time channel attention proposed in this study is inspired by this approach. The ordinary channel attention mechanism is applied to the time interval, and the time channel attention is denoted as the time-SE module.

    For narrative convenience, this subsection uses $ X $ as the output of the intermediate layer and $ X $ as the input for the analogous case. $ V = \{v_1, v_2, \cdots, v_c\} $ denotes the convolution kernel used in the convolution, where $ v_c $ represents the parameters of the cth convolution kernel. The convolution result is denoted as $ U = \{u_1, u_2, \cdots, u_c\} $, and the convolution result of the cth convolution kernel is.

    $ uc=vcX
    $
    (3.7)

    From Eq (3.7), it is clear that the transformations in the temporal convolutional network alone cannot "focus" on the temporal information in the data that is relevant to the prediction task. In this study, we solve this problem using the temporal channel attention time-SE module.

    The time-SE module, shown in Figure 4, is built in two steps: first, the squeeze module is built to extract the global information on the time "channel"; second, the excitation module calculates and reassigns the attention mechanism to the corresponding time interval based on the global information provided by squeeze.

    Figure 4.  Causal dilation convolution.

    $ {\bf{Squeeze \ module}} $: This module compresses the information of the convolution result of a temporal convolutional network in a time interval into a time descriptor. The time descriptor was implemented by considering the global average pooling operation to generate time-dependent statistics. Formally, a statistic $ z\in\mathbb{R}^{c} $ is implemented by compressing $ U $ in the dimension $ N\times C $. The tth element of $ z $ is computed by Eq (3.8):

    $ zt=Fsq(vt)=1N×CHi=1Hi=1vt(i,j)
    $
    (3.8)

    where $ z_t $ is the output of the squeeze module and, $ v_t $ is the convolution result at time $ t $.

    $ {\bf{Excitation \ module}} $: This module uses the squeeze module to obtain global information, calculate the attention of the time channel, and allocate different "importance" to different time intervals. To apply the gating mechanism to the excitation module, a formal calculation of this operation is shown in Eq (3.9):

    $ s=Fex(z,W)=σ(g(z,W))=σ(w2σ(W1z))
    $
    (3.9)

    where $ \sigma $ refers to the $ ReLU $ activation function, $ W_1\in\mathbb{R}^{\frac{1}{r} \times T} $, and $ W_2\in\mathbb{R}^{\frac{1}{r} \times T} $, and $ s $ is the time channel attention mechanism. To limit the complexity of the model and thus enhance its generalization, two fully connected layers $ (FC) $ are added before the nonlinear transformation, that is, a descending layer with parameter $ W_1 $, a $ ReLU $ layer, and an ascending layer with parameter $ W_2 $.

    $ ˜xt=Fscale(vt,st)=stvt
    $
    (3.10)

    where $ \tilde{X} = \{ \tilde{x}_1, \tilde{x}_2, \cdots, \tilde{x}_t \} $, $ s_t $ is the time channel attention term assigned to time $ t $ and $ v_t\in\mathbb{R}^{N \times C} $ is the result of convolving the data at time $ t $. The time-SE module introduces dynamics in which the inputs are conditional (changes in time channel attention that occur with different inputs), which improves the ability of the model to distinguish the features of the data in time.

    The feature channel attention $ m $ and time channel attention $ s_t $ are calculated separately on the convolution results, and then multiplied with the convolution result to obtain different attention output results $ \bar{x}_c $ and $ \tilde{x}_t $. The output results under the two-channel attention are summed to obtain the extracted features $ F_t $, as shown in Eq (3.11):

    $ Ft=ˉxc+˜xt
    $
    (3.11)

    The features $ F_t $ are input into the feedforward neural network, and the probability of the onset of sepsis pt for the patient is derived using the softmax activation function, as shown in Eq (3.12):

    $ pt=softmax(Ft)
    $
    (3.12)

    In this study, the cross-entropy loss function is used as the loss function $ L $ between the true value $ a_t $ and the predicted value $ p_t $, and the minimization $ L $ is used to optimize the input of the patient's physiological features, network parameters and to predict the probability of sepsis onset in patients. The loss function $ L $ is calculated as shown in Eq (3.13).

    $ L=Ni=1[(atlogpt)+(1at)log(1pt)]
    $
    (3.13)

    The implementation of the temporal convolution attention model for sepsis diagnosis prediction is presented in Algorithm 1.

    Algorithm 1 Algorithm of example
    Input: Patient Information $ H=\{ h_1, h_2, \cdots, h_n \} $, $ T=\{ t_1, t_2, \cdots, t_j \} $, Number of layer $ L $, Residual blocks $ B $, Training hyperparameters
    Output: The probability that the patient has sepsis $ p_t $
    1:  for $ h_t = \{Z_t|temp_k, heartrate_k, spo2_k, \cdots \} $ do// input physiological features into TCN
    2:     $ F(s)=(x \ast _df)(s)=\sum_{i=0}^kf(i)\cdot x_{s-d\cdot i} $
    3:     $ F_{tr}=Activation(x+F(x)) $
    4:     for $ \bar{x}_c = m \cdot u_c $ do // feature channel attention weighted
    5:         $ m = V_{1\times1}\ast U $
    6:          $ u_c = v_c \ast X $
    7:     end for
    8:     for $ \tilde{x}_t = F_{scale}(v_t, s_t)=s_t\cdot v_t $ do // time channel attention weighted
    9:          $ z_t = F_{sq}(v_t)=\frac{1}{N \times C} \sum\limits_{i=1}^{H} \sum\limits_{i=1}^{H} v_t(i, j) $
    10:          $ s = F_{ex}(z, W) =\sigma(g(z, W)) = \sigma(w_2\sigma(W_1z)) $
    11:          $ v_t\in\mathbb{R}^{N \times C} $
    12:      end for
    13:   end for
    14:  $ F_t = \bar{x}_c + \tilde{x}_t $ // weighted sum of two sets of features
    15:  $p_t=softmax(F_t) $ // return to the incidence of sepsis in patients
    16:  Calculate the cross-entropy loss function $ L $
    17:  Model optimization, parameter update
    18:  Return $ p_t $ // return the optimized result

     | Show Table
    DownLoad: CSV

    In this study, we used the EMRs dataset MIMIC-Ⅲ [41] provided by Beth Israel Deaconess Medical Center, U.S.A. The MIMIC-Ⅲ dataset contains information on multiple types of ICUs (surgical care units, medical care units, trauma surgical care units, neonatal care units, and cardiac care units) and includes vital signs, medications, laboratory measurements, medical orders, procedure codes, diagnosis codes, imaging reports, length of stay, and survival data. The longitudinal medical records used for this study collected data on over $ 58, 000 $ visits to $ 38, 645 $ adults and $ 7875 $ newborns seen at the medical center between $ 2001 $ and $ 2012 $. Institutional approval was obtained to use the deidentified data for research purposes.

    Data were extracted from the MIMIC-Ⅲ dataset according to the latest international consensus definition of sepsis, which is commonly used to assess the effectiveness of treatment in patients with suspected infection at risk of sepsis.

    First, accurate and timely determination of the time of onset of sepsis is critical. SOFA (as shown in Table 1) is a scoring system for determining the degree of impairment of major organ function after a patient is admitted to the ICU ward, and a SOFA score $ \ge2 $ indicates that the patient is at risk of suspected sepsis infection. Therefore, in this study, the time of SOFA score $ \ge2 $ after the patient's admission to the ICU was determined as the onset of suspected sepsis infection.

    Table 1.  Sequential organ failure assessment.
    ${\textbf{Score}}$
    ${\textbf{System}}$ ${\textbf{Variable}}$ ${\textbf{0}}$ ${\textbf{1}}$ ${\textbf{2}}$ ${\textbf{3}}$ ${\textbf{4}}$
    Respiration PaO2/FiO2, mmHg $ \ge400 $ $<400 $ $<300 $ $<200 $ $<100 $
    respiratory support Yes Yes
    Coagulation Platelets, $ 10^9 $/L $ \ge150 $ $<150 $ $<100 $ $<50 $ $<20 $
    Liver Bilirubin, $ \mu $mol/L $<20.5 $ $ \le34.1 $ $ \le102.5 $ $ \le205.1 $ $>205.2 $
    Cardiovascular MAP, mmHg $ \ge70 $ $<70 $
    Dopamine, $ \mu $g/(kg$ \cdot $min) $ \le5 $ $>5 $ $>15 $
    dobutamine, $ \mu $g/(kg$ \cdot $min) any dose
    epinephrine, $ \mu $g/(kg$ \cdot $min) $ \le0.1 $ $>0.1 $
    norepinephrine, $ \mu $g/(kg$ \cdot $min) $ \le0.1 $ $>0.1 $
    Central nervous system Glasgow Coma Scale score $ 15 $ $ 13 $--$ 14 $ $ 10 $--$ 12 $ $ 6 $--$ 9 $ $<6 $
    Renal Creatinine, $ \mu $mol/L $<110 $ $ \le176 $ $ \le308 $ $ \le442 $ $>442 $
    Urine output, ml/d $ \le500 $ $ \le200 $

     | Show Table
    DownLoad: CSV

    Second, the following criteria were used for patient inclusion in the trial: (1) patients admitted to the ICU who were older than $ 18 $ years, with a high prevalence of sepsis; (2) ICU stay of over $ 24 $ h to ensure sufficient data for analysis, and (3) patients diagnosed with sepsis according to the international consensus definition. In addition, to ensure that nonseptic patients did not develop sepsis before ICU admission, the data center for nonseptic patients was required to have no ICD-$ 9 $ codes associated with sepsis.

    Finally, $ 24 $ dynamic features related to sepsis were selected for the experiment (as shown in Table 2). After screening the data, $ 17, 227 $ patients were finally selected, including $ 6769 $ patients with sepsis and $ 10, 458 $ patients without sepsis.

    Table 2.  Dynamic features list of sepsis.
    Vital Features Lab Features
    Mean blood pressure Platelet Bicarbonate
    Respiratory rate Potassium Creatinine
    Heart rate Pulse transit time Chloride
    Pulse oximetry International normalized ratio Glucose
    Systolic blood pressure Prothrombin time Hematocrit
    Diastolic blood pressure Sodium Hemoglobin
    Body temperature Blood urea nitrogen Lactate
    White blood cells Magnesium
    Blood gas pH

     | Show Table
    DownLoad: CSV

    Note: (1) Daily assessment should take the worst daily value; (2) Higher scores indicate a worse prognosis.

    The data obtained after extraction from the MIMIC-Ⅲ dataset cannot be used directly for sepsis prediction, and further processing of the experimental data is required.

    (1) Filling in missing data values: The typical solutions for missing data are deletion and mean interpolation; however, considering that medical data have sampling irregularity and uncertainty, there are certain problems in solving missing medical data using these methods. Therefore, the experiments used MGP to solve the missing data problem. It generates a continuous function to fit irregular samples by modeling the data covariance. Because it can easily account for uncertainty and does not require uniformly sampled data, it is the ideal solution for handling irregularly sampled medical time series.

    (2) Data normalization: The prediction results are affected by the units of measurement of each feature value, for example, $ 90 $ $ \le $ systolic blood pressure $ \le $ $ 140 $, $ 60 $ $ \le $ diastolic blood pressure $ \le $ $ 90 $, $ 16 $ $ \le $ respiratory rate $ \le $ $ 20 $. Normalization can limit the data to a certain range, thus eliminating the adverse effects caused by odd sample data. The normalization of the data accelerates the gradient descent to obtain the optimal solution and potentially improve accuracy.

    To verify the effectiveness of the proposed TCASP model, five representative models were selected for comparison experiments:

    Logistic regression [42] is a generalized linear regression analysis model that classifies data based on the available data by creating a regression formula for the classification boundary line.

    Insight [43] is an early warning algorithm that has been developed for the early detection of septic infections in clinical settings.

    RNN [44] is a type of neural network with short-term memory capacity and are used to process sequential data.

    LSTM [45] network is a type of recurrent neural network after improvement, which can solve long-distance dependence.

    TCN [46] is a network structure capable of processing time-series data and outperforming traditional neural networks under certain conditions.

    In this study, we used TensorFlow $ 2.0 $ to implement the TCASP model. All experiments were conducted on a GPU server with $ 192 $G RAM, RTX$ 6000 $ graphics card, and Ubuntu Server $ 18.04 $. The dataset was divided into training, validation, and test sets at a ratio of $ 8:1:1 $. The experimental parameters of the TCASP model are listed in Table 3.

    Table 3.  Experimental parameters.
    Parameter Description Value
    Learning rate $ 0.0005 $
    Batch size $ 128 $
    Number of epochs $ 100 $
    Dropout rate $ 0.05 $
    kernel size $ 2 $–$ 6 $
    Residual blocks $ 2 $–$ 12 $
    Hidden layers $ 10 $–$ 55 $
    L2 regularisation $ 0 $–$ 250 $

     | Show Table
    DownLoad: CSV

    The sepsis prediction problem investigated in this study is essentially a binary classification learning problem. There are two main types of evaluation metrics for binary classification learning problems: AUROC and AUPRC. The sepsis prediction aims to identify a patient's risk of infection as early as possible, and the larger the area of the AUROC and AUPRC, the better the prediction effect. The indicators are briefly described as follows:

    (1) AUROC: This metric is a randomly selected pair of samples (positive and negative samples) us-ing a classifier that has been trained to predict a probability value for the positive and negative samples, respectively. The probability that the probability of the positive sample is greater than the probability of the negative sample is the AUROC, and the formula is

    $ AUC=insipositiveclassrankinsiM×(M+1)2M×N
    $
    (4.1)

    where $ \sum_{ins_i\in positiveclass} $ denotes the ordinal numbers of positive samples, $ rank_{ins_i} $ denotes the number of the $ i $th sample, and $ M, N $ denotes the number of positive and negative samples.

    (2) AUPRC: The PRC curve is the line formed by the points of accuracy and recall, and is plotted with accuracy as the vertical axis and recall as the horizontal axis to obtain the recall-accuracy curve, referred to as the "PR curve".

    In addition to the two evaluation metrics mentioned earlier, decision curve analysis (DCA) and clinical impact curve (CIC), which are widely used in clinical analysis, are used in this study for comparison of logistic, Insight, RNN, LSTM, TCN and TCASP models. The metrics are briefly described below.

    (1) DCA is a simple method for evaluating clinical predictive models, diagnostic tests, and molecular markers. While traditional diagnostic assays, such as sensitivity, specificity, and area under the ROC curve, only measure the diagnostic accuracy of predictive models and fail to consider the clinical utility of a particular model, the DCA can integrate patient or decision-maker preferences into the analysis. This concept meets the practical needs of clinical decision making.

    $ Nb=tpcnfpcn(pt1pt)
    $
    (4.2)

    where $ Nb $ is the net benefit, $ tpc $ is the true positive count, $ fpc $ is the false positive count, $ n $ is the total number, and $ p_t $ is the threshold probability.

    (2) The CIC is a further development of the DCA algorithm, which is used in clinical settings to assess the predictive accuracy of predictive models.

    This study aims to identify patients at risk of sepsis infection as early as possible and to minimize mortality in patients with sepsis. Therefore, the diagnostic accuracy of the TCASP prediction model is particularly important. Figures 5 shows the comparison of AURPC and AUPRC values for sepsis onset under different algorithms.

    Figure 5.  Comparison of AUROC and AUPRC values for sepsis onset under different algorithms.

    (1) The analysis of the experimental results in Figures 5 shows that within 6 hours before sepsis onset, the AUROC and AUPRC indexes of the TCASP model continue to rise, indicating that the probability of sepsis infection of patients increased continuously, with the highest values reaching $ 86.9\% $ and $ 63.9\% $, respectively, which are far higher than those of other prediction models. This indicates that TCASP is the most suitable model for the early prediction of the first infection of sepsis in ICU patients. (2) As shown in the time complexity comparison in Table 4, where $ n $ is the number of training samples, $ t $ is the sequence length, and $ d $ is the vector dimension, the time complexity of the TCASP model in this study is $ O(n\ast d^2 + t \ast d^2) $. The time complexity of logistics is the lowest among the compared methods, and the time complexity of TCASP is slightly higher than that of TCN. Therefore, there is a need for continuous optimization in terms of time complexity to improve the prediction performance of the model.

    Table 4.  Time complexity comparison.
    Algorithm Logistic Insight RNN LSTM TCN TCASP
    Time Complexity $ O(n\ast d) $ $ O(n\ast d^2) $ $ O(n\ast d+ t\ast d) $ $ O(n\ast d^2+ t\ast d) $ $ O(n\ast d^2+ t\ast d) $ $ O(n\ast d^2+ t\ast d^2) $

     | Show Table
    DownLoad: CSV

    To verify the effectiveness of MGP in the early diagnosis and prediction of sepsis, we compared five commonly used methods for handling missing values. According to the experimental results shown in Table 5, using MGP for missing value imputation yielded excellent results for the subsequent TCASP model in sepsis early diagnosis and prediction.This is because MGP can utilize the correlations between multiple tasks (i.e., different features) to impute missing values. By considering information from multiple features, the imputed values can more accurately reflect the actual condition of the patients, providing more comprehensive data. Single-task Gaussian process is also a flexible and effective method for handling missing values, but it is only suitable for imputing missing values in a single feature and cannot fully leverage the correlations between features. Nearest neighbor interpolation method can fill in missing values based on the nearest neighboring data points to the missing values, but it may not be robust enough in the presence of noise or outliers. Mean imputation and median imputation are simple and common methods that fill in missing values using the mean or median of the entire feature. These methods can preserve the overall statistical characteristics of the data to some extent but may overlook the correlations between features. Deleting missing values is the simplest approach, but it may result in a reduction in the amount of data and introduce bias in predictions.In summary, this study chose to use MGP to handle missing values in multivariate time series features because it can better leverage the correlations between features, providing more accurate and comprehensive data.

    Table 5.  Comparison of missing value handling methods.
    Model Missing Value Handling AUROC AUPRC
    TCASP Delete Missing Values 70.5 ± 2.8 50.4 ± 3.0
    Mean Imputation 73.1 ± 1.0 53.9 ± 1.7
    Median Imputation 76.8 ± 1.7 56.3 ± 0.9
    Nearest Neighbor Interpolation 79.4 ± 2.6 58.6 ± 1.5
    Single-task Gaussian Process 81.2 ± 1.2 60.1 ± 1.0
    Multi-task Gaussian Process 86.9 ± 0.6 63.9 ± 1.3

     | Show Table
    DownLoad: CSV

    In our model, we use an attention mechanism to enhance the selection of multivariate time-series features in the TCASP model, considering the specificity of medical datasets, which helps improve the prediction performance of the entire model. We conducted ablation experiments to demonstrate the effectiveness of the attention mechanism in the model for selecting important features and temporal information. The TCASP model consists of three parts: temporal convolutional network, feature channel attention ($ \alpha $), and time channel attention ($ \beta $), and the entire TCASP model is split with the other three parts for comparison of the ablation experiments, and the results are shown in Tables 6 and 7.

    Table 6.  Area under the ROC curve for the ablation experiment.
    Hours before sepsis onset TCASP w/o $ \alpha $ TCASP w/o $ \beta $ TCASP w/o attention TCASP
    6 h 65.2 ± 2.1 61.1 ± 1.9 57.4 ± 2.6 73.5 ± 0.6
    5 h 67.5 ± 1.8 64.2 ± 1.0 60.9 ± 1.7 73.9 ± 1.2
    4 h 69.8 ± 0.9 66.0 ± 0.4 62.8 ± 1.2 74.2 ± 0.4
    3 h 71.2 ± 1.2 68.3 ± 0.7 64.3 ± 1.0 76.5 ± 1.0
    2 h 73.4 ± 0.4 71.2 ± 0.9 69, 4 ± 0.8 81.3 ± 0.3
    1 h 76.1 ± 0.6 74.9 ± 0.5 72.6 ± 0.5 83.0 ± 0.5
    0 h 79.5 ± 0.4 77.4 ± 0.7 74.2 ± 0.6 86.9 ± 0.6

     | Show Table
    DownLoad: CSV
    Table 7.  Area under the precision-recall curve for the ablation experiment.
    Hours before sepsis onset TCASP w/o $ \alpha $ TCASP w/o $ \beta $ TCASP w/o attention TCASP
    6 h 48.5 ± 1.8 47.7 ± 1.0 45.7 ± 1.5 50.4 ± 2.0
    5 h 49.3 ± 1.6 48.4 ± 1.5 47.0 ± 1.3 51.3 ± 1.2
    4 h 50.1 ± 1.1 50.2 ± 1.2 49.3 ± 0.9 54.7 ± 1.1
    3 h 51.6 ± 1.5 51.3 ± 1.3 50.6 ± 1.7 57.9 ± 1.0
    2 h 53.7 ± 1.3 53.3 ± 1.7 51.1 ± 0.9 60.3 ± 1.2
    1 h 55.1 ± 1.4 54.7 ± 1.8 52.0 ± 1.0 62.7 ± 0.7
    0 h 59.9 ± 1.2 56.7 ± 1.2 54.4 ± 1.3 63.9 ± 1.3

     | Show Table
    DownLoad: CSV

    To verify the effect of the attention mechanism on the importance of multivariate time series features, we removed the entire attention mechanism module at the input layer of feature extraction. To verify the effect of time channel attention ($ \beta $) on the importance of selecting temporal information, we removed the time channel attention in the attention mechanism module. To verify the effect of the feature channel attention ($ \alpha $) on the importance of selecting important features, we removed the feature channel attention in the attention mechanism module.

    By analyzing the results of the ablation experiments in Tables 6 and 7, we find that (1) the prediction performance is optimal when the model has the entire attention mechanism module, indicating that the attention mechanism significantly influences the model performance. (2) As the results of the ablation experiments indicate, the prediction performance of the model was significantly reduced by removing any part of the attention mechanism module. This is because the model does not select important features and temporal information more accurately after removing two-channel attention. (3) The ablation experiments show that as the number of patients in the EMRs increases, the patient data also increases exponentially. If important patient information is not extracted for the patient, it will bring a huge computational overhead to patient condition prediction and auxiliary diagnosis. The experiments in this study verify the effectiveness of the attention mechanism module in the TCASP model, which is beneficial for improving prediction performance.

    In actual clinical diagnosis, we predict whether a patient has sepsis using the patient's physiological features, and no matter which feature value is selected as the threshold, we will encounter false positives and negatives, that is, misdiagnosis and underdiagnosis, sometimes avoiding false positives will benefit the patient the most, and sometimes it is more desirable to avoid false negatives, and to attempt to avoid these two situations, decision curves are commonly used. Figure 6 shows the decision curve analysis of the six prediction models. The x-axis represents the threshold probability of critical care outcomes, and the y-axis represents the net benefit.

    Figure 6.  Decision curve analysis of six prediction models.

    As shown in Figure 6, we can see that the TCASP model has the highest net benefit, while the Logistic regression model has the lowest net benefit. This is because the Logistic regression model has stricter requirements for features, needing them to satisfy the assumptions of linearity and independence. If there are non-linear features or highly correlated features in the sepsis prediction task, the Logistic regression model may not effectively utilize this information, thereby affecting the performance of net benefit. At the same time, as the threshold probability increases, the net benefit of the TCN model gradually decreases. This is due to the local nature of convolutional operations, which may pose challenges for TCN in handling long-term dependencies. In the sepsis prediction task, long-term temporal dependencies may be crucial for accurate predictions. The TCASP model effectively addresses both of these issues by combining temporal and feature attention mechanisms, achieving the best net benefit in the DCA curve. If the risk of a patient hi suffering from sepsis is recorded as $ p_i $, and when $ p_i $ reaches the corresponding threshold, it is regarded to be positive, which means that the doctor can refer to the DCA index to take corresponding treatment measures in advance for patients suspected to be infected with sepsis; this will not only predict the probability that the patient may suffer from sepsis so that the patient's condition can be controlled early but also reduce the probability of misdiagnosis and avoid causing double losses to the patient's mental and property.

    The CIC visualization of the TCASP model is shown in Figure 7. In the CIC, the x-axis indicates the threshold probability of critical care outcomes, and the y-axis indicates the number of high risk individuals. The red curve indicates the number of people classified as positive (high risk population) by the TCASP model at each threshold, and the blue curve indicates the number of true positives (actual occurrence of the high risk population) at each threshold.

    Figure 7.  Clinical impact curve of the TCASP model.

    As shown in Figure 7, according to the CIC analysis results, when the threshold exceeds $ 50\% $, the TCASP model identifies a number of individuals as high-risk sepsis patients that highly matches the actual number of high-risk sepsis patients. This indicates that the TCASP model has high predictive accuracy at high thresholds, meaning that the model tends to classify individuals with higher probabilities as high-risk patients. At the same time, the model's positive predictions match the actual number of positives, which means that at high thresholds, the model can effectively identify true high-risk patients, thus providing good clinical utility. This is crucial for the early diagnosis and intervention of sepsis, as it helps doctors better identify high-risk patients and take appropriate treatment measures promptly. However, it is important to note that for lower threshold probabilities, the model's predictions may have some errors, meaning that the model may miss some true high-risk individuals. Therefore, in practical applications, doctors and clinical decision-makers need to balance the trade-off between accuracy and missed diagnosis rate and choose an appropriate threshold based on specific circumstances.

    We proposed the TCASP model comprehensively considered the uncertainty of EMRs and used the multitask Gaussian process to tackle the missing data. We introduced a dual channel attention mechanism, which enables the model to "independently" select relevant features, and solve the problem of difficulty in focusing on important features and time information owing to the huge and complex EMRs. The TCASP model can focus on the time-series information and predict the time of first sepsis infection in ICU patients.

    However, the TCASP model also has some shortcomings: (1) Although introducing the time channel attention mechanism in the model can focus on time information, which can improve the effect of feature learning, it also improves the time complexity. (2) The experimental data in this study came only from an internationally open dataset. In this dataset, the proportion of male patients was relatively high, and the number of white patients was relatively high, which may have led to a potential demographic bias. (3) Our dataset analysis may be insufficient, leading to some key feature variables not being included in the TCASP model.

    In future studies, we aim to further improve the model to enable it to identify high risk sepsis patients more comprehensively, accurately, and promptly. We aim to further improve the TCASP model, reduce the time complexity, provide technical support for clinical assistant diagnosis, personalized diagnosis, and treatment of sepsis, and improve the level of smart medical services.

    We would like to thank the anonymous reviewers for their valuable comments. This research was funded by the Northwest Normal University Major Research Project Incubation Program, China (No. NWNU-LKZD2021-06).

    The authors declare there is no conflict of interest.

    [1] Deming TJ (2014) Preparation and development of block copolypeptide vesicles and hydrogels for biological and medical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 6: 283–297.
    [2] Crucho CIC (2015) Stimuli-Responsive Polymeric Nanoparticles for Nanomedicine. Chem Med Chem 10: 24–38. doi: 10.1002/cmdc.201402290
    [3] Hamidi M, Shahbazi MA, Rostamizadeh K (2012) Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy. Macromol Biosci 12: 144–164. doi: 10.1002/mabi.201100193
    [4] Kamaly N, Xiao Z, Valencia PM, et al (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 41: 2971–3010. doi: 10.1039/c2cs15344k
    [5] Fleige E, Quadir MA, Haag R (2012) Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 64: 866–884. doi: 10.1016/j.addr.2012.01.020
    [6] Motornov M, Roiter, Y, Tokarev I, et al. (2010) Stimuli-responsive nanoparticles, nanogels and capsules for integrated multifunctional intelligent systems. Prog Polym Sci 35: 174–211. doi: 10.1016/j.progpolymsci.2009.10.004
    [7] Gong J, Chen M, Zheng Y, et al (2012) Polymeric micelles drug delivery system in oncology. J Control Release 159: 312–323.
    [8] Kowalczuk A, Trzcinska R, Trzebicka B, et al. (2014) Loading of polymer nanocarriers: factors, mechanisms and applications. Prog Polym Sci 39: 43–86. doi: 10.1016/j.progpolymsci.2013.10.004
    [9] Zhang Y, Wang C, Huang Y, et al. (2015) Core-crosslinked polymeric micelles with high doxorubicin loading capacity and intracellular pH- and redox-triggered payload release. Eur Polym J 68: 104–114.
    [10] Aluri S, Janib SM, Mackay JA (2009) Environmentallyresponsivepeptides as anticancer drug carriers. Adv Drug Deliver Rev 61: 940–952. doi: 10.1016/j.addr.2009.07.002
    [11] Doty P, Yang JT (1956) Polypeptides VII. Poly-gamma-benzyl-L-glutamate—the helix-coil transition in solution. J Am Chem Soc 78:498–500.
    [12] Blout ER, Lenormant H (1957) Reversible configurational changes in poly-L-lysine hydrochloride induced by water. Nature 179: 960–963. doi: 10.1038/179960a0
    [13] Applequist J (1963) On helix-coil equilibrium in polypeptides. J Chem Phys 38: 934–941. doi: 10.1063/1.1733787
    [14] Soliman M, Allen S, Davies MC, et al. (2010) Responsive polyelectrolyte complexes for triggered release of nucleic acid therapeutics. Chem Commun 46: 5421–5433. doi: 10.1039/c0cc00794c
    [15] Rosu C, Selcuk S, Soto-Cantu E, et al. (2014) Progress in silica polypeptide composite colloidal hybrids: from silica cores to fuzzy shells. Colloid Polym Sci 292: 1009-1040. doi: 10.1007/s00396-014-3170-7
    [16] Holowka EP, Sun VZ, Kamei DT, et al. (2007) Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery. Nat Mater 6 :52–57.
    [17] Battaglia G, Ryan AJ (2005) Bilayers and Interdigitation in Block Copolymer Vesicles. J Am Chem Soc 127: 8757–8764.
    [18] Won YY, Davis HT, Bates FS (1999) Giant Wormlike Rubber Micelles. Science 283: 960–963.
    [19] Geng Y, Dalhaimer P, Cai S, et al. (2007) Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery. Nat Nanotechnol 2: 249–255. doi: 10.1038/nnano.2007.70
    [20] Robertson JD, Yealland G, Avila-Olias, et al. (2014) pH-sensitive tubular polymersomes: Formation and applications in cellular delivery. ACS Nano 8: 4650–4661. doi: 10.1021/nn5004088
    [21] Quadir MA, Martin M, Hammond PT (2014) Clickable Synthetic Polypeptides—Routes to New Highly Adaptive Biomaterials. Chem Mater 26: 461–476. doi: 10.1021/cm4023997
    [22] Such GK, Yan Y, Johnston APR, et al. (2015) Interfacing Materials Science and Biology for Drug Carrier Design. Adv Mater 27: 2278–2297. doi: 10.1002/adma.201405084
    [23] Van Sluis R,Bhujwalla ZM,Raghunand N, et al. (1999) In Vivo Imaging of Extracellular pH Using 1H MRSI. Magnet Reson Med 41:743–750.
    [24] Brahimi-Horn MC,Pouyssegur J (2007)Hypoxia in cancer cell metabolism and pH regulation. Essays Biochem 43: 165–178.
    [25] Qiu Y, Park K (2001) Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 53: 321–39. doi: 10.1016/S0169-409X(01)00203-4
    [26] Majedi FS, Hasani-Sadrabadi MM, VanDersarl JJ, et al. (2013) On-Chip Fabrication of Paclitaxel-Loaded Chitosan Nanoparticles for Cancer Therapeutics. Adv Funct Mater 24: 432–41.
    [27] Bajaj I, Singhal R (2011) Poly (glutamic acid)—an emerging biopolymer of commercial interest. Bioresource Technol 102: 5551–5561. doi: 10.1016/j.biortech.2011.02.047
    [28] Kim W, Yamasaki Y, Jang WD, at al. (2010) Thermodynamics of DNA condensation induced by poly (ethylene glycol)-block-polylysine through polyion complex micelle formation. Biomacromolecules 11: 1180–1186. doi: 10.1021/bm901305p
    [29] Bellomo E, Wyrsta MD, Pakstis L, et al. (2004) Stimuli-responsive polypeptide vesicles by conformation-specific assembly. Nat Mater 3: 244−248.
    [30] Nowak AP, Breedveld V, Pakstis L, et al. (2002) Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature 417: 424−428.
    [31] Holowka EP, Pochan DJ, Deming TJ (2005) Charged Polypeptide Vesicles with Controllable Diameter. J Am Chem Soc 127: 12423–12428. doi: 10.1021/ja053557t
    [32] Carlsen A, Lecommandoux S (2009) Self-assembly of polypeptide-based block copolymer amphiphiles. Curr Opin Colloid In 14: 329–339. doi: 10.1016/j.cocis.2009.04.007
    [33] Quadir MA, Morton SW, Deng ZJ, et al. (2014) PEG–Polypeptide Block Copolymers as pH-Responsive Endosome-Solubilizing Drug Nanocarriers. Mol Pharmaceutics11: 2420–2430.
    [34] Yin H, Kang SW, Bae YH (2009) Polymersome Formation from AB2 Type 3-Miktoarm Star Copolymers. Macromolecules 42: 7456–7464. doi: 10.1021/ma901701w
    [35] Yin H, Kang HC, Huh KM, et al. (2012) Biocompatible, pH-sensitive AB2 miktoarm polymer-based polymersomes: preparation, characterization, and acidic pH-activated nanostructural transformation. J Mater Chem 22: 19168–19178.
    [36] Kragh-Hansen H, Chuang VT, Otagiri M (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Bio Pharm Bull 25: 695–704 doi: 10.1248/bpb.25.695
    [37] Ming X, Carver K, Wu L (2013) Albumin-Based Nanoconjugates for Targeted Delivery of Therapeutic Oligonucleotides. Biomaterials 34: 7939–7949. doi: 10.1016/j.biomaterials.2013.06.066
    [38] Du C, Deng D, Shan L, at al. (2013) A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery. Biomaterials 34: 3087–3097. doi: 10.1016/j.biomaterials.2013.01.041
    [39] Xia W, Low PS (2010) Folate-targeted therapies for cancer. J Med Chem 53: 6811–6824. doi: 10.1021/jm100509v
    [40] Sudimack J, Lee RJ (2000) Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41: 147–162. doi: 10.1016/S0169-409X(99)00062-9
    [41] Lu Y, Low PS (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 54: 675–693. doi: 10.1016/S0169-409X(02)00042-X
    [42] Nistor MT, Chiriac AP, Nita LE, et al. (2013) Semi-interpenetrated polymer networks of hyaluronic acid modified with poly(aspartic acid). J Polym Res 20: 86. doi: 10.1007/s10965-013-0086-8
    [43] Mackay JA, Chilkoti A (2008) Temperature sensitive peptides: engineering hyperthermia-directed therapeutics. Int J Hypertherm 24: 483–495. doi: 10.1080/02656730802149570
    [44] Aluri S, Janib SM, Mackay JA (2009) Environmentally responsive peptides as anticancer drug carriers. Adv Drug Deliver Rev 61: 940–952. doi: 10.1016/j.addr.2009.07.002
    [45] Ruszczak Z (2003) Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55: 1595–1611. doi: 10.1016/j.addr.2003.08.003
    [46] Lupas A (1996) Coiled coils: new structures and new functions. Trends Biochem Sci 21: 375–382. doi: 10.1016/S0968-0004(96)10052-9
    [47] Petka WA, Harden JL, McGrath KP, et al. (1998) Reversible hydrogels from self-assembling artificial proteins. Science 281: 389–392.
    [48] Al-Ahmady ZS, Al-Jamal WT, Bossche JV, et al. (2012) Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia in Vitro and in Vivo. ACS Nano 6: 9335–9346. doi: 10.1021/nn302148p
    [49] Banta S, Wheeldon IR, Blenner M (2010) Protein engineering in the development of functional hydrogels. Annu Rev Biomed Eng 12:167–186. doi: 10.1146/annurev-bioeng-070909-105334
    [50] Huang HC, Koria P, Parker S, et al. (2008) Optically responsive gold nanorod-polypeptide assemblies. Langmuir 24: 14139–14144. doi: 10.1021/la802842k
    [51] Lin Y, Xia X, Wang M, et al. (2014) Genetically programmable thermoresponsive plasmonic gold/silk-elastin protein core/shell nanoparticles. Langmuir 30: 4406–4414.
    [52] Chilkoti A, Dreher MR, Meyer DE, et al. (2002) Targeted drug delivery by thermally responsive polymers. Adv Drug Deliver Rev 54: 613–630. doi: 10.1016/S0169-409X(02)00041-8
    [53] Maeda H, Seymour LW, Miyamoto Y (1992) Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem 3: 351–362. doi: 10.1021/bc00017a001
    [54] Schmaljohann D (2006) Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliver Rev 58: 1655–1670.
    [55] Raucher D, Massodi I, Bidwell GL (2008) Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin like polypeptide. Expert Opin Drug Deliver 5: 353–369. doi: 10.1517/17425247.5.3.353
    [56] Massodi I, Thomas E, Raucher D (2009) Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules 14: 1999–2015. doi: 10.3390/molecules14061999
    [57] MacEwan SR, Chilkoti A (2010) Elastin-like polypeptides: biomedical applications of tunable biopolymers. Biopolymers 94: 60–77. doi: 10.1002/bip.21327
    [58] Liu W, Dreher MR, Furgeson DY, et al (2006) Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J Control Release 116: 170–178. doi: 10.1016/j.jconrel.2006.06.026
    [59] McDaniel JR, Callahan DJ, Chilkoti A, et al. (2010) Drug delivery to solid tumors by elastin-like polypeptides. Adv Drug Deliver Rev 62: 1456–1467. doi: 10.1016/j.addr.2010.05.004
    [60] Moktan S, Ryppa C, Kratz F, et al. (2012) A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis. Invest New Drugs 30: 236–248. doi: 10.1007/s10637-010-9560-x
    [61] Rousselle C, Smirnova M, Clair P, et al. (2001) Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J Pharmacol Exp Ther 296: 124–13.
    [62] Jiang C, Tsukruk VV, et al. (2006) Freestanding Nanostructures via Layer-by-Layer Assembly. Adv Mater 18: 829–840.
    [63] Johnston APR, Cortez C, Angelatos AS, et al. (2006) Layer-by-layer engineered capsules and their applications. Curr Opin Colloid Interface Sci 11: 203–209.
    [64] Wattendorf U, Kreft O, Textor M, et al. (2008) Stable stealth function for hollow polyelectrolyte microcapsules through a poly(ethylene glycol) grafted polyelectrolyte adlayer. Biomacromolecules 9: 100–108.
    [65] Kamphuis MM, Johnston AP, Such GK, et al. (2010) Targeting of cancer cells using click-functionalized polymer capsules. J Am Chem Soc 132: 15881–15883.
    [66] Golonka M, Bulwan M, Nowakowska M, et al. (2011) Thermoresponsive multilayer films based on ionic elastin-like recombinamers. Soft Matter 7: 9402–9409. doi: 10.1039/c1sm06276j
    [67] Chen X, Zhang W, Li K, et al. (2012) Thermoresponsive oligoprolines. Soft Matter 8: 4869–4872. doi: 10.1039/c2sm25451d
    [68] Chen C, Wang Z, Li Z (2011) Thermoresponsive Polypeptides from Pegylated Poly-l-glutamate. Biomacromolecules 12: 2859–2863. doi: 10.1021/bm200849m
    [69] Fu X, Shen Y, Fu W (2013) Thermoresponsive Oligo(ethylene glycol) Functionalized Poly-l-cysteine. Macromolecules46: 3753–3760.
    [70] Zhang X, Li W, Zhao X, et al. (2013) Thermoresponsive Dendronized Polyprolines via the “Grafting to” Route. Macromol Rapid Commun 34: 1701–1707. doi: 10.1002/marc.201300605
    [71] Yan J, Liu K, Zhang X, at al. (2015) Dynamic covalent polypeptides showing tunable secondary structures and thermoresponsiveness. J Polym Sci A 53: 33–41. doi: 10.1002/pola.27433
    [72] Lam RTS, Belenguer A, Roberts SL (2005) Amplification of Acetylcholine-Binding Catenanes from Dynamic Combinatorial Libraries. Science 308: 667–669. doi: 10.1126/science.1109999
    [73] Carnall JMA, Waudby CA, Belenguer AM, et al (2010) Mechanosensitive Self-Replication Driven by Self-Organization. Science 327: 1502–1506. doi: 10.1126/science.1182767
    [74] Li J, Nowak P, Otto S (2013) Dynamic Combinatorial Libraries: From Exploring Molecular Recognition to Systems Chemistry. J Am Chem Soc 135: 9222–9239. doi: 10.1021/ja402586c
    [75] Matanović MR, Kristl J, Grabnar PA (2014) Thermoresponsive polymers: Insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications. Int J Pharm 472: 262–275.
    [76] Joly-Duhamel C, Hellio D, Djabourov M (2002) All gelatin networks: 1. Biodiversity and physical chemistry. Langmuir 18: 7208–7217.
    [77] Yang H, Kao W (2006) Thermoresponsive gelatin/monomethoxy poly(ethylene glycol)–poly(d,l-lactide) hydrogels: formulation, characterization, and antibacterial drug delivery. Pharm Res 23: 205–214.
    [78] Ohya S, Matsuda T (2005) Poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artificial extracellular matrix: molecular and formulation parameters vs. cell proliferation potential. J Biomat Sci-Polym 16: 809–827.
    [79] Huang J, Hastings CL, Duffy GP, et al. (2013) Supramolecular Hydrogels with Reverse Thermal Gelation Properties from (Oligo)tyrosine Containing Block Copolymers. Biomacromolecules 14: 200–206. doi: 10.1021/bm301629f
    [80] Cheng Y, He C, Xiao C, et al. (2012) Decisive Role of Hydrophobic Side Groups of Polypeptides in Thermosensitive Gelation. Biomacromolecules 13: 2053–2059. doi: 10.1021/bm3004308
    [81] Park MH, Joo MK, Choi BG, et al. (2012) Biodegradable Thermogels. Acc Chem Res 45: 424–433.
    [82] Oh HJ, Joo MK, Sohn YS, et al. (2008) Secondary Structure Effect of Polypeptide on Reverse Thermal Gelation and Degradation of l/dl-Poly(alanine)–Poloxamer–l/dl-Poly(alanine) Copolymers. Macromolecules 41:8204–8209.
    [83] Zhang S, Fu W, Li Z (2014) Supramolecular hydrogels assembled from nonionic poly(ethylene glycol)-b-polypeptide diblocks containing OEGylated poly-L-glutamate. Polym Chem 5: 3346–3351.
    [84] Zhang DJ, Alvarez MV, Sofroniew TJ (2015) Deming. Design and Synthesis of Nonionic Copolypeptide Hydrogels with Reversible Thermoresponsive and Tunable Physical Properties. Biomacromolecules16: 1331–1340.
    [85] Huang J, Bonduelle C, Thévenot J, et al. (2012) Biologically Active polymersomes from Amphiphilic Glycopeptides. J Am Chem Soc 134: 119–122. doi: 10.1021/ja209676p
    [86] Schatz C, Louguet S, Meins JFL, et al. (2009) Polysaccharide block polypeptide copolymers vesicles towards synthetic viral capsids. Angew Chem Int Ed 48: 2572–2575. doi: 10.1002/anie.200805895
    [87] Zhang A, Zhang Z, Shi F, et al. (2013) Redox-Sensitive Shell-Crosslinked Polypeptide-block-Polysaccharide Micelles for Efficient Intracellular Anticancer Drug Delivery. Macromol Biosci 13: 1249–1258. doi: 10.1002/mabi.201300175
    [88] Liu L, Liu P (2015) Synthesis strategies for disulfide bond-containing polymer-based drug delivery system for reduction-responsive controlled release. Front Mater Sc 9: 211–226. doi: 10.1007/s11706-015-0283-y
    [89] Wang K, Luo GF, Liu Y, et al. (2012) Redox-sensitive shell cross-linked PEG-polypeptidehybrid micelles for controlled drug release. Polym Chem 3: 1084–1090. doi: 10.1039/c2py00600f
    [90] Beloor J, Ramakrishna S, Nam K, et al. (2015) Effective Gene Delivery into Human Stem Cells with a Cell-Targeting Peptide-Modified Bioreducible Polymer. Small 11: 2069–2079. doi: 10.1002/smll.201402933
    [91] Burnett JC, Rossi JJ (2012) RNA-Based Therapeutics: Current Progress and Future Prospects. Chem Biol 19: 60–71. doi: 10.1016/j.chembiol.2011.12.008
    [92] Cavalieri F, Beretta G, Cui J, et al. (2015) Redox-Sensitive PEG–Polypeptide Nanoporous Particles for Survivin Silencing in Prostate Cancer Cells. Biomacromolecules 16: 2168–2178. doi: 10.1021/acs.biomac.5b00562
    [93] Wang Y, Yu A, Caruso F (2005) Nanoporous Polyelectrolyte Spheres Prepared by Sequentially Coating Sacrificial Mesoporous Silica Spheres. Angew Chem Int Ed 44: 2888–2892. doi: 10.1002/anie.200462135
    [94] Manickam DS, Oupický D (2006) Multiblock Reducible Copolypeptides Containing Histidine-Rich and Nuclear Localization Sequences for Gene Delivery. Bioconjugate Chem17: 1395–1403.
    [95] Rosengart AJ, Kaminski MD, Chen HT, et al. (2005) Magnetizable implants and functionalized magnetic carriers: a novel approach for noninvasive yet targeted drug delivery. J Magn Magn Mater 293: 633–638
    [96] Mornet S, Vasseur S, Grasset F, et al. (2006) Magnetic nanoparticle design for medical applications. Prog Solid State Ch 34: 237–47. doi: 10.1016/j.progsolidstchem.2005.11.010
    [97] Lee H, Shao HP, Huang YQ, et al. (2005) Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan. IEEE T Magn 41:4102–4.
    [98] Liu XQ, Kaminski MD, Riffle JS, et al. (2007) Preparation and characterization of biodegradable magnetic carriers by single emulsion-solvent evaporation. J Magn Magn Mater 311: 84–7. doi: 10.1016/j.jmmm.2006.10.1170
    [99] Ju XJ, Xie R, Yang L (2009) Biodegradable ‘intelligent’ materials in response to physical stimuli for biomedical applications. Expert Opin Ther Pat 19: 493–507. doi: 10.1517/13543770902771282
    [100] Aili D, Stevens MM (2010) Bioresponsive peptide-inorganic hybrid nanomaterials. Chem Soc Rev 39: 3358–3370. doi: 10.1039/b919461b
    [101] Pan BF, Cui DX, Sheng Y, et al. (2007) Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 67: 8156–8163. doi: 10.1158/0008-5472.CAN-06-4762
    [102] Digigow RG, Dechézelles JF, Dietsch H, et al. (2014) Preparation and characterization of functional silica hybrid magnetic nanoparticles. J Magn Magn Mater 362: 72–79.
    [103] Digigow RG, Vanhecke D, Rothen-Rutishauser B, et al. (2015)Uptake and Intracellular Fate of Peptide Surface-Functionalized Silica Hybrid Magnetic Nanoparticles In Vitro. Part Part Syst Char 33: 188–196.
    [104] Lerche MH, Jensen PR, Karlsson M, et al. (2015) NMR Insights into the Inner Workings of Living Cells. Anal Chem 87: 119–132.
    [105] Boutin C, Desvaux H, Carrière M, et al. (2011) Hyperpolarized129Xe NMR signature of living biological cells. NMR Biomed 24: 1264–1269. doi: 10.1002/nbm.1686
    [106] Kotera N, Dubost E, Milanole G, et al. (2015) A doubly responsive probe for the detection of Cys4-tagged proteins. Chem Commun 51: 11482–11484. doi: 10.1039/C5CC04721H
    [107] Kwon S, Kim BJ, Lim HK, et al. (2015) Magnetotactic molecular architectures from self-assembly of β-peptide foldamers. Nat Commun 6: 8747. doi: 10.1038/ncomms9747
    [108] Goodman CM, Choi S, Shandler S, et al. (2007) Foldamers as versatile frameworks for the design and evolution of function. Nat Chem Biol 3: 252–262. doi: 10.1038/nchembio876
    [109] Kwon S, Jeon A, Yoo S, et al. (2010) Unprecedented Molecular Architectures by the Controlled Self-Assembly of a β-Peptide Foldamer. Angew Chem Int Ed 49: 8232–8236. doi: 10.1002/anie.201003302
    [110] Lefèvre CT, Abreu F, Lins U, et al. (2011) A bacterial backbone: magnetosomes in magnetotactic bacteria. M. Rai, N. Duran (Eds.) in Metal nanoparticles in microbiology, Springer-Verlag, Berlin (2011), 75–102.
    [111] Unger E, Metzger P, Krupinski E, et al. (2000) The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol 35: 86–89. doi: 10.1097/00004424-200001000-00010
    [112] Weller GER, Wong MKK, Modzelewski RA, et al. (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65: 533–539.
    [113] Linker RA, Reinhardt M, Bendszus M, et al. (2005) In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimmun 25:199–205.
    [114] Sirsi S, Borden M (2009) Microbubble compositions, properties and biomedical applications. Bubble Sci Eng Technol 1: 3–17. doi: 10.1179/175889709X446507
    [115] Cochran MC, Eisenbrey J, Ouma RO, et al. (2011) Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 414:161–170. doi: 10.1016/j.ijpharm.2011.05.030
    [116] Borden MA, Sarantos MR, Stieger SM (2006) Ultrasound radiation force modulates ligand availability on targeted contrast agents. Mol Imag 5:139–147.
    [117] Lum AFH, Borden MA, Dayton PA (2006) Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 111: 128–134. doi: 10.1016/j.jconrel.2005.11.006
    [118] Borden MA,Zhang H, Gillies RJ, et al. (2008) A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 29: 597–606. doi: 10.1016/j.biomaterials.2007.10.011
    [119] Bloch M, Jablonowski L, Yavin E, et al. (2015) Multi-modal detection of colon malignancy by NIR-tagged recognition polymers and ultrasound contrast agents. Int J Pharm 478: 504–516. doi: 10.1016/j.ijpharm.2014.11.066
    [120] Eisenbrey JR, Burstein OM, Kambhampati R, et al. (2010) Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery. J Control Release 143: 38–44. doi: 10.1016/j.jconrel.2009.12.021
    [121] Eisenbrey JR, Soulen MC, Wheatley MA (2010) Delivery of encapsulated doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents. IEEE Trans Biomed Eng 57: 24–28. doi: 10.1109/TBME.2009.2030497
    [122] Duncan R, Gac-Breton S, Keane R (2001) Polymer-drug conjugates, PDEPT and PELT: basic principles for design and tranfer from the laboratory to clinic. J Control Release 74: 135–46. doi: 10.1016/S0168-3659(01)00328-5
    [123] Terada T, Iwai M, Kawakami S (2006) Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting. J Control Release 111: 333–42.
    [124] Lee SJ, Jeong YI, Park HK, et al. (2015) Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancerdrug delivery. Int J Nano 10: 5489–550.
    [125] Secret E, Kelly SJ, Crannell KE, et al. (2014) Enzyme-Responsive Hydrogel Microparticles for Pulmonary Drug Delivery. ACS Appl Mater Interfaces 6: 10313–10321. doi: 10.1021/am501754s
    [126] Secret E, Crannell KE, Kelly SJ, et al. (2015) Matrix metalloproteinase-sensitive hydrogel microparticles for pulmonary drug delivery of small molecule drugs or proteins. J Mater Chem B 3: 5629–5634. doi: 10.1039/C5TB00443H
    [127] Angelos S, Khashab NM, Yang YW, et al. (2009) pH clock-operated mechanized nanoparticles. J Am Chem Soc 131: 12912–12914.
    [128] Luo Z, Ding X, Hu Y, et al. (2013) Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo. ACS Nano 7: 10271–10284. doi: 10.1021/nn404676w
    [129] Li J, Liu F, Shao Q, et al. (2014) Enzyme-Responsive Cell-Penetrating Peptides Conjugated Mesoporous Silica Quantum Dots Nanocarriers for Controlled Release of Nucleus-Targeted Drug Molecules and Real-Time Intracellular Fluorescence Imaging of Tumor Cells. Adv Healthcare Mater 3: 1230–123. doi: 10.1002/adhm.201300613
    [130] Cheng YJ, Luo GF, Zhu JY, et al. (2015) Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles. ACS Appl Mater Interfaces7: 9078–9087.
    [131] Liu J, Zhang B, Luo Z, et al. (2015) Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Nanoscale 7: 3614–3626. doi: 10.1039/C5NR00072F
    [132] del Mercato LL, Ferraro MM, Baldassarre F, et al. (2014) Biological applications of LbL multilayer capsules: From drug delivery to sensing. Adv Colloid Interface Sci 207: 139–154. doi: 10.1016/j.cis.2014.02.014
    [133] De Geest BG, Vandenbroucke RE, Guenther AM, et al. (2006) Intracellularly degradable polyelectrolyte microcapsules. Adv Mater 18: 1005–1009. doi: 10.1002/adma.200502128
    [134] Ochs CJ, Such GK, Yan Y, et al. (2010) Biodegradable click capsules with engineered drug-loaded multilayers. Acs Nano 4: 1653–1663. doi: 10.1021/nn9014278
    [135] Aller SG, Yu J, Ward A, et al. (2009) Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding. Science 323: 1718–1722. doi: 10.1126/science.1168750
    [136] Yan Y, Ochs C, Such G, et al. (2010) Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules. Adv Mater 22: 5398–5403. doi: 10.1002/adma.201003162
    [137] Zhao Y (2007) Rational design of light-controllable polymer micelles. Chem Rec 7: 286–294. doi: 10.1002/tcr.20127
    [138] Alatorre-Meda M, Alvarez-Lorenzo C, Concheiro A, et al. (2013) UV and Near-IR Triggered Release from Polymeric Micelles and Nanoparticles, in Smart Materials for Drug Delivery (Eds.: C. Alvarez-Lorenzo, A. Concheiro), RSC Publishing,Cambridge 304–348.
    [139] Hernanz D, Nunez V, Sancho A, et al. (2001) Hydroxycinnamic acids and ferulic acid dehydrodimers in barley and processed barley. J Agric Food Chem 49: 4884–4888. doi: 10.1021/jf010530u
    [140] Hoff WD, Dux P, Hard K, et al. (1994) Thiol ester-linked p-coumaric acid as a new photoactive prosthetic group in a protein with rhodopsin-like photochemistry. Biochemistry 33: 13959–13962. doi: 10.1021/bi00251a001
    [141] Wang G, Tong X, Zhao Y (2004) Preparation of Azobenzene-Containing Amphiphilic Diblock Copolymers for Light-Responsive Micellar Aggregates. Macromolecules 37: 8911–8917. doi: 10.1021/ma048416a
    [142] Shi D, Matsusaki M, Kaneko T, et al. (2008) Photo-Cross-Linking and Cleavage Induced Reversible Size Change of Bio-Based Nanoparticles. Macromolecules 41: 8167–8172. doi: 10.1021/ma800648e
    [143] Zhao Y (2012) Light-Responsive Block Copolymer Micelles. Macromolecules 45: 3647–3657. doi: 10.1021/ma300094t
    [144] Kotharangannagari VK, Sánchez-Ferrer A, Ruokolainen J, et al. (2011) Photo-Responsive Reversible Aggregation and Dissolution of Rod-Coil Polypeptide Diblock Copolymers. Macromolecules 44: 4569–4573. doi: 10.1021/ma2008145
    [145] Kumar S, Allard JF, Morris D, et al. (2012) Near-infrared light sensitive polypeptide block copolymer micelles for drug delivery. J Mater Chem 22: 7252–7257. doi: 10.1039/c2jm16380b
    [146] Li Y, Qian Y, Liu T, et al. (2012) Light-triggered concomitant enhancement of magnetic resonance imaging contrast performance and drug release rate of functionalized amphiphilic diblock copolymer micelles. Biomacromolecules 13: 3877–3886. doi: 10.1021/bm301425j
    [147] Liu G, Liu N, Zhou L, et al. (2015) NIR-responsive polypeptide copolymer upconversion composite nanoparticles for triggered drug release and enhanced cytotoxicity. Polym Chem 6: 4030–4039
    [148] Martinez-Cuezva A, Valero-Moya S, Alajarin M, et al. (2015) Light-responsive peptide [2]rotaxanes as gatekeepers of mechanised nanocontainers. Chem Commun 51: 14501–14504. doi: 10.1039/C5CC04365D
    [149] Stoddart JF (ed) (2001) Special issue on molecular machines. Acc Chem Res 34: 410 (2001).
    [150] Cavallini M, Biscarini F, Leon S (2003) Information Storage Using Supramolecular Surface Patterns.Science 299: 531–531. doi: 10.1126/science.1078012
    [151] Bottari G, Leigh DA, Pérez EM (2003) Chiroptical Switching in a Bistable Molecular Shuttle. J Am Chem.Soc125: 13360–13361.
    [152] Pernites RB, Santos CM, Maldonado M, et al. (2012) Tunable Protein and Bacterial Cell Adsorption on Colloidally Templated Superhydrophobic Polythiophene Films. Chem Mater 24: 870–880. doi: 10.1021/cm2007044
    [153] Gomez N, Schmidt CE (2007) Nerve growth factor-immobilized polypyrrole: Bioactive electrically conducting polymer for enhanced neurite extension. J Biomed Mater Res 81: 135–149.
    [154] Green RA, Lovell NH, Poole-Warren LA (2009) Cell attachment functionality of bioactive conducting polymers for neural interfaces. Biomaterials 30: 3637–3644. doi: 10.1016/j.biomaterials.2009.03.043
    [155] Zhong Y, Yu X, Gilbert R, et al (2001) Stabilizing electrode-host interfaces: a tissue engineering approach. J Rehabil Res Dev 38: 627–632.
    [156] Fabregat G, Ballano G, Armelin E (2013) An electroactive and biologically responsive hybrid conjugate based on chemical similarity. Polym Chem 4: 1412–1424. doi: 10.1039/C2PY20894F
    [157] Maione S, Gil AM, Fabregat G, et al. (2015) Electroactive polymer–peptide conjugates for adhesive biointerfaces. Biomater Sci 3: 1395–1405. doi: 10.1039/C5BM00160A
    [158] Jeon G, Yang SY, Byun J, et al. (2011) Electrically actuatable smart nanoporous membrane for pulsatile drug release. Nano Lett 11: 1284–1288. doi: 10.1021/nl104329y
    [159] Ge J, Neofytou E, Cahill TJ, et al. (2012) Drug release from electric-field-responsive nanoparticles. ACS Nano 6: 227–233. doi: 10.1021/nn203430m
    [160] Wu L, Wang J, Gao N, et al. (2015) Electrically pulsatile responsive drug delivery platform for treatment of Alzheimer’s disease. Nano Res 8: 2400–2414. doi: 10.1007/s12274-015-0750-x
    [161] Santos JL, Li Y, Culver HR, et al. (2014) Conducting polymer nanoparticles decorated with collagen mimetic peptides for collagen targeting. Chem Commun 50: 15045–15048.
    [162] Cheng R, Meng F, Deng C, et al. (2013) Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34: 3647–3657. doi: 10.1016/j.biomaterials.2013.01.084
    [163] Dai J, Lin SD, Cheng D, et al. (2011) Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed 50: 9404–9408. doi: 10.1002/anie.201103806
    [164] Yu S, Wu G, Gu X, et al. (2013) Magnetic and pH-sensitive nanoparticles for antitumor drug deliver. Colloids Surf B 103: 15–22. doi: 10.1016/j.colsurfb.2012.10.041
    [165] Remant BKC, Thapa B, Xu P (2012) pH and Redox Dual Responsive Nanoparticle for Nuclear Targeted Drug Delivery. Mol Pharmaceutics 9: 2719–2729.
    [166] Gupta MK, Lee SH, Crowder SW, et al. (2015) Oligoproline-derived nanocarrier for dual stimuli-responsive gene delivery. J Mater Chem 3: 7271–7280. doi: 10.1039/C5TB00988J
  • This article has been cited by:

    1. Samaneh Nasiri, Kai Wang, Mingjun Yang, Qianqian Li, Michael Zaiser, Nickel coated carbon nanotubes in aluminum matrix composites: a multiscale simulation study, 2019, 92, 1434-6028, 10.1140/epjb/e2019-100243-6
    2. Samaneh Nasiri, Christian Greff, Kai Wang, Mingjun Yang, Qianqian Li, Paolo Moretti, Michael Zaiser, Multilayer Structures of Graphene and Pt Nanoparticles: A Multiscale Computational Study, 2020, 22, 1438-1656, 2000207, 10.1002/adem.202000207
    3. Konstantin P. Katin, Konstantin S. Krylov, Mikhail M. Maslov, Vadim D. Mur, Tuning the supercritical effective charge in gapless graphene via Fermi velocity modifying through the mechanical stretching, 2019, 100, 09259635, 107566, 10.1016/j.diamond.2019.107566
    4. Mohammed Javeed Akhter, Wacław Kuś, Adam Mrozek, Tadeusz Burczyński, Mechanical Properties of Monolayer MoS2 with Randomly Distributed Defects, 2020, 13, 1996-1944, 1307, 10.3390/ma13061307
    5. Mobin Shakeri, Effect of randomly distributed asymmetric stone-wales defect on electronic and transport properties of armchair graphene nanoribbon, 2019, 128, 07496036, 116, 10.1016/j.spmi.2019.01.019
    6. 2022, 9781119975922, 143, 10.1002/9781118536445.ch4
    7. Samaneh Nasiri, Michael Zaiser, Effects of elasticity and dislocation core structure on the interaction of dislocations with embedded CNTs in aluminium: An atomistic simulation study, 2022, 21, 25891529, 101347, 10.1016/j.mtla.2022.101347
    8. Samaneh Nasiri, Guang Yang, Erdmann Spiecker, Qianqian Li, An Improved Approach to Manufacture Carbon Nanotube Reinforced Magnesium AZ91 Composites with Increased Strength and Ductility, 2022, 12, 2075-4701, 834, 10.3390/met12050834
    9. Samaneh Nasiri, Kai Wang, Mingjun Yang, Julien Guénolé, Qianqian Li, Michael Zaiser, Atomistic aspects of load transfer and fracture in CNT-reinforced aluminium, 2022, 22, 25891529, 101376, 10.1016/j.mtla.2022.101376
    10. Samaneh Nasiri, Kai Wang, Mingjun Yang, Julien Géunolé, Qianqian Li, Michael Zaiser, Atomistic Aspects of Load Transfer and Fracture in CNT-Reinforced Aluminium, 2021, 1556-5068, 10.2139/ssrn.3955670
    11. Jonas Ritter, Shucheta Shegufta, Michael Zaiser, Effects of disorder on deformation and failure of brittle porous materials, 2023, 2023, 1742-5468, 053301, 10.1088/1742-5468/acccdf
    12. Pavel A. Kulyamin, Aleksey I. Kochaev, Mikhail M. Maslov, Roberto Flores-Moreno, Savas Kaya, Konstantin P. Katin, Electronic and optical characteristics of graphene on the molybdenum ditelluride substrate under the uniform mechanical stress, 2023, 140, 09259635, 110547, 10.1016/j.diamond.2023.110547
    13. Laurent Proville, Anshuman Choudhury, Unravelling the jerky glide of dislocations in body-centred cubic crystals, 2024, 23, 1476-1122, 47, 10.1038/s41563-023-01728-5
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(11134) PDF downloads(1816) Cited by(7)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog